SHIFT AI Newsroom · GLOBAL
Case Report: Unilateral Graves' Disease Linked to Tirzepatide in Diabetes Patient
A recent case report published on Europe PMC highlights a rare instance of unilateral Graves' disease developing in a patient with diabetes who was being treated with Tirzepatide.
A recent case report published on Europe PMC highlights a rare instance of unilateral Graves' disease developing in a patient with diabetes who was being treated with Tirzepatide. The report suggests a potential link between Tirzepatide treatment and the development of this condition, but further research is needed to confirm this association.
What this means in the UK
This case report may be relevant to UK healthcare professionals and patients with diabetes who are being treated with Tirzepatide, as it highlights a rare but potentially significant side effect.
Known facts
- A case report published on Europe PMC describes a patient with diabetes who developed unilateral Graves' disease while being treated with Tirzepatide.